For almost three decades, the “Best Managed Companies” title has been a highly esteemed title awarded to exceptional private businesses globally, implemented in 48 countries.
Vinmec has been awarded the prestigious title of “Best Managed Company in Vietnam” for 2022, making it the only medical institution to receive this award.
In order to attain this sought-after title, companies must pass a rigorous evaluation of a Judging Panel, which assesses their performance in four key areas: Business strategy; Competitiveness and Innovation; Corporate Culture; and Corporate Governance and Finance. The process includes analysis of businesses’ corporate strategy and operations, in accordance with a specific assessment framework widely-applied in 1,200 Best Managed Companies worldwide.
Vinmec has become the first medical institution in the country to be honored, having passed this rigorous independent assessment process and meeting all four management criteria. With this title, Vinmec has officially become a member of a network of distinguished global enterprises, which presents a promising opportunity for the company to expand into new markets and pioneer in its field.
Ms. Le Thuy Anh – General Director of Vinmec Healthcare System – spoke at the ceremony.
Mr. Pham Dinh Huynh – Director of the Private Sector Division at Deloitte Vietnam – shared: “I was very impressed with Vinmec this award season, having witnessed their serious investment in an effective management system. The entire Vinmec team, from medical staff to executives, are collaborative, scientific, and methodical. By being selected as the Best Managed Company, Vinmec has demonstrated their capability and commitment to devising and executing a clear and sound business strategy, in order to achieve superior operational outcomes and pursue Vinmec’s academic medicine objectives.
Notaly, this marks the first time a private healthcare system is awarded this title in Vietnam. This is a milestone for hospital management, where Vinmec is a pioneering model that exemplifies dual-development and mutual support between an academic medicine system and an excellent management system.
Leaders of Deloitte Vietnam with Vinmec Healthcare System’s Leadership Board
Speaking at the Ceremony, Ms. Le Thuy Anh – General Director of Vinmec Healthcare System shared: “In this new decade, Vinmec aims to become an academic medicine institution with a top-notch clinical management apparatus. This will be the model for continuous and comprehensive healthcare management, which provides exceptional service to customers and members, ultimately becoming the preferred healthcare provider for the people”.
Vinmec places a significant emphasis on governance to effectively bolster the growth of its academic medicine system. All of Vinmec’s 7 general hospitals and 3 international clinics are required to adhere to professional management standards in line with global standards. Two hospitals within the system, namely Vinmec Times City International General Hospital and Vinmec Central Park International General Hospital, are JCI-accredited. This is widely regarded as the most rigorous certification of hospital quality and patient safety in the world. Additionally, Vinmec Times City is CAP-accredited, which is recognized as the highest laboratory standard worldwide. Over the past decade, Vinmec has made significant strides not only in management and quality, but also in its core professional disciplines, including cardiology, oncology, orthopedic, stem cells, etc.
With customers at the core of its business – Vinmec has seen remarkable success in both its treatment and management quality, after 1 decade of development.
Vinmec’s efforts have been recognized with the Best Managed Companies Award. In the near future, Vinmec aims to achieve additional international quality standards, including ACC (cardiology), RTAC (assisted reproduction), and AABB (tissue bank). Additionally, Vinmec plans to enhance its management capabilities through international collaborations with renowned healthcare systems, such as the Cleveland Clinic (USA), Seoul National University Hospital (South Korea), GE Healthcare (USA), Roche Pharma, and so on. Its ultimate goal is to provide the best healthcare services to all patients.
To book an appointment, please dial HOTLINE or book directly HERE. Download and book an automatic appointment on the MyVinmec application to manage, track the schedule and book an appointment anytime, anywhere.
Sarcoma is a rare yet highly malignant group of cancers, with bone cancer and soft tissue cancer being two groups that require complex diagnostic and treatment processes. Soon, patients in Vietnam will gain access to a new reputable facility for comprehensive sarcoma treatment that has been evaluated by Cleveland Clinic (USA).
Bone and soft tissue cancer (sarcoma) is a rare form of highly malignant, easily misdiagnosed cancer that requires complicated treatment - a host of challenges that make its treatment in Vietnam remains a big gap. This situation leads to remarkable disadvantages for the majority of patients.
The prevalence of heart failure in the Southeast Asia region is significantly higher than the rest of the world (4.5–6.7% compared to 0.5–2%) [1]. In the case of cardiac hospitals in Vietnam, heart failure patients account for 15% of total admissions, with a readmission rate within 30 days after discharge rising up to 7% [2].
Recently, the conference on Quality Assurance Team for Radiation Oncology (QUATRO) took place at Vinmec Central Park International General Hospital, attracting many experts and leaders from leading Oncology hospitals across the country. The conference aims to discuss safety requirements, as well as quality assurance standards in radiotherapy practice.
